AMPK: Lessons from transgenic and knockout animals.

AMP-activated protein kinase (AMPK), a phylogenetically conserved serine/threonine protein kinase, has been proposed to function as a fuel gauge to monitor cellular energy status in response to nutritional environmental variations. AMPK system is a regulator of energy balance that, once activated by low energy status, switches on ATP-producing catabolic pathways (such as fatty acid oxidation and glycolysis), and switches off ATP-consuming anabolic pathways (such as lipogenesis), both by short-term effect on phosphorylation of regulatory proteins and by long-term effect on gene expression. Numerous observations obtained with pharmacological activators and agents that deplete intracellular ATP have been supportive of AMPK playing a role in the control of energy metabolism but none of these studies have provided conclusive evidence. Relatively recent developments in our understanding of precisely how AMPK complexes might operate to control energy metabolism is due in part to the development of transgenic and knockout mouse models. Although there are inevitable caveats with genetic models, some important findings have emerged. In the present review, we discuss recent findings obtained from animal models with inhibition or activation of AMPK signaling pathway.

[1]  C. C. Hale,et al.  Metabolic activation of AMP kinase in vascular smooth muscle. , 2005, Journal of applied physiology.

[2]  R. Heath,et al.  Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family* , 2007, Journal of Biological Chemistry.

[3]  Ki-Up Lee,et al.  Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis , 2005, Journal of Molecular Medicine.

[4]  B. Viollet,et al.  Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver , 2006, Molecular Pharmacology.

[5]  B. Spiegelman,et al.  AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α , 2007, Proceedings of the National Academy of Sciences.

[6]  D. Hardie,et al.  Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase* , 2005, Journal of Biological Chemistry.

[7]  Peter Schjerling,et al.  Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[8]  J. Balschi,et al.  Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. , 2007, American journal of physiology. Heart and circulatory physiology.

[9]  M. J. Vazquez,et al.  Central administration of resistin promotes short-term satiety in rats. , 2005, European journal of endocrinology.

[10]  Michael D. Schneider,et al.  A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway , 2006, Proceedings of the National Academy of Sciences.

[11]  G. Ronnett,et al.  Developing a head for energy sensing: AMP‐activated protein kinase as a multifunctional metabolic sensor in the brain , 2006, The Journal of physiology.

[12]  J. Seidman,et al.  AMP-Activated Protein Kinase in the Heart: Role During Health and Disease , 2007, Circulation research.

[13]  P. Neufer,et al.  Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  W. G. Wiles,et al.  Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo , 2004, Journal of Biological Chemistry.

[15]  B. Viollet,et al.  [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases]. , 2006, Medecine sciences : M/S.

[16]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[17]  B. Viollet,et al.  AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits , 2006, Diabetes.

[18]  L. Bertrand,et al.  Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. , 2002, European journal of biochemistry.

[19]  J. Wojtaszewski,et al.  AS160 phosphorylation is associated with activation of α2β2γ1- but not α2β2γ3-AMPK trimeric complex in skeletal muscle during exercise in humans , 2007 .

[20]  L. Bertrand,et al.  Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. , 2002, Journal of molecular and cellular cardiology.

[21]  Ferhaan Ahmad,et al.  A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. , 2007, Biochemical and biophysical research communications.

[22]  S. Gordon,et al.  Impaired overload‐induced muscle growth is associated with diminished translational signalling in aged rat fast‐twitch skeletal muscle , 2006, The Journal of physiology.

[23]  L. Bertrand,et al.  AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. , 2006, American journal of physiology. Heart and circulatory physiology.

[24]  J. Seidman,et al.  Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. , 2007, The Journal of clinical investigation.

[25]  S. Gordon,et al.  Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation. , 2005, Journal of applied physiology.

[26]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[27]  P. Saha,et al.  Increased β-Oxidation but No Insulin Resistance or Glucose Intolerance in Mice Lacking Adiponectin* , 2002, The Journal of Biological Chemistry.

[28]  M. Steinmetz,et al.  Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5'AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique. , 2004, European journal of biochemistry.

[29]  B. Kemp,et al.  Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation. , 2007, American journal of physiology. Endocrinology and metabolism.

[30]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[31]  Roy J Martin,et al.  Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. , 2005, Endocrinology.

[32]  C. Kahn,et al.  Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3 , 2006, Molecular and Cellular Biology.

[33]  P. Lawrence,et al.  Genes in development , 1977, Nature.

[34]  D. Hardie,et al.  AMP-activated protein kinase as a drug target. , 2007, Annual review of pharmacology and toxicology.

[35]  B. Viollet,et al.  AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. , 2007, Diabetes.

[36]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[37]  M. Lane,et al.  The Role of Hypothalamic Malonyl-CoA in Energy Homeostasis* , 2006, Journal of Biological Chemistry.

[38]  A. Ashworth,et al.  Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. , 2006, American journal of physiology. Endocrinology and metabolism.

[39]  B. Viollet,et al.  5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. , 2006, Diabetes.

[40]  B. Viollet,et al.  Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. , 2006, Endocrinology.

[41]  D. Bolster,et al.  AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling* , 2002, The Journal of Biological Chemistry.

[42]  J. Olefsky,et al.  Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. , 2004, The Journal of clinical investigation.

[43]  L. Witters,et al.  The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. , 2001, Biochemical and biophysical research communications.

[44]  B. Viollet,et al.  AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. , 2007, The Biochemical journal.

[45]  L. McCullough,et al.  Pharmacological Inhibition of AMP-activated Protein Kinase Provides Neuroprotection in Stroke* , 2005, Journal of Biological Chemistry.

[46]  D. Hardie,et al.  Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. , 1996, The American journal of physiology.

[47]  S. Gygi,et al.  An AMPK-FOXO Pathway Mediates Longevity Induced by a Novel Method of Dietary Restriction in C. elegans , 2007, Current Biology.

[48]  P. Distefano,et al.  Aging networks in Caenorhabditis elegans: AMP‐activated protein kinase (aak‐2) links multiple aging and metabolism pathways , 2006, Aging cell.

[49]  B. Viollet,et al.  Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[50]  L. Rossetti,et al.  Molecular disruption of hypothalamic nutrient sensing induces obesity , 2006, Nature Neuroscience.

[51]  G. Shulman,et al.  Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. , 2001, American journal of physiology. Endocrinology and metabolism.

[52]  B. Viollet,et al.  Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders , 2006, The Journal of physiology.

[53]  M. Birnbaum,et al.  Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. , 2001, Biochemical Society transactions.

[54]  D. Befroy,et al.  Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis , 2007, Cell metabolism.

[55]  I. Tabata,et al.  Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. , 2002, Biochemical and biophysical research communications.

[56]  J. Zierath,et al.  5′‐AMP‐activated protein kinase regulates skeletal muscle glycogen content and ergogenics , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  Jun Hee Lee,et al.  Energy-dependent regulation of cell structure by AMP-activated protein kinase , 2007, Nature.

[58]  D. St Johnston,et al.  LKB1 and AMPK maintain epithelial cell polarity under energetic stress , 2007, The Journal of cell biology.

[59]  T. Shimokawa,et al.  The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  B. Viollet,et al.  Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. , 2006, American journal of physiology. Heart and circulatory physiology.

[61]  R. Coleman,et al.  AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. , 1999 .

[62]  D. Hardie,et al.  AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.

[63]  M. Bohlooly-y,et al.  Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism , 2007, Diabetes.

[64]  Kei Sakamoto,et al.  Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction , 2005, The EMBO journal.

[65]  G. Lopaschuk,et al.  AMPK alterations in cardiac physiology and pathology: enemy or ally? , 2006, The Journal of physiology.

[66]  Jean Girard,et al.  Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. , 2005, The Journal of clinical investigation.

[67]  D. Carling,et al.  Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinase , 1994, FEBS letters.

[68]  B. Kemp,et al.  Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. , 2001 .

[69]  J. Apfeld,et al.  The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. , 2004, Genes & development.

[70]  B. Viollet,et al.  Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. , 2007, American journal of physiology. Heart and circulatory physiology.

[71]  Rene,et al.  THE AMERICAN JOURNAL OF PHYSIOLOGY. , 1897, Science.

[72]  D. Grahame Hardie,et al.  Possible involvement of AMP‐activated protein kinase in obesity resistance induced by respiratory uncoupling in white fat , 2004, FEBS letters.

[73]  R. Russell,et al.  AMP-activated protein kinase: a key stress signaling pathway in the heart. , 2005, Trends in cardiovascular medicine.

[74]  O. Ljungqvist,et al.  Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. , 2000, Biochemical and biophysical research communications.

[75]  Russell G. Jones,et al.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.

[76]  D. Vertommen,et al.  New targets of AMP-activated protein kinase. , 2001, Biochemical Society transactions.

[77]  F. Dela,et al.  5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes , 2005, The Journal of physiology.

[78]  B. Kemp,et al.  Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.

[79]  E. D. Muse,et al.  Hypothalamic resistin induces hepatic insulin resistance. , 2007, The Journal of clinical investigation.

[80]  R. Palanivel,et al.  Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin , 2005, FEBS letters.

[81]  N. Fujii,et al.  Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation. , 2006, American journal of physiology. Endocrinology and metabolism.

[82]  B. Viollet,et al.  Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. , 2004, Diabetes.

[83]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[84]  P. Neufer,et al.  Effects of α‐AMPK knockout on exercise‐induced gene activation in mouse skeletal muscle , 2005 .

[85]  B. Viollet,et al.  Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. , 2007, The Journal of physiology.

[86]  P. Bénit,et al.  S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. , 2007, Cell metabolism.

[87]  G. Ronnett,et al.  C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase* , 2004, Journal of Biological Chemistry.

[88]  M. Raney,et al.  AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction. , 2005, American journal of physiology. Endocrinology and metabolism.

[89]  J. Schneider,et al.  Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2006, American journal of physiology. Heart and circulatory physiology.

[90]  Roberto Conti,et al.  Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.

[91]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[92]  W. Winder,et al.  Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. , 2000, Journal of applied physiology.

[93]  G. Hjälm,et al.  The 5′-AMP-activated Protein Kinase γ3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle* , 2004, Journal of Biological Chemistry.

[94]  R. Tian,et al.  AMP‐activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP‐sensitive K+ channels , 2007, Journal of cellular physiology.

[95]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[96]  N. Fujii,et al.  Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. , 2003, The Journal of biological chemistry.

[97]  G. Shulman,et al.  Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. , 2001, Diabetes.

[98]  M. Raney,et al.  Regulation of contraction-induced FA uptake and oxidation by AMPK and ERK1/2 is intensity dependent in rodent muscle. , 2006, American journal of physiology. Endocrinology and metabolism.

[99]  O. Pedersen,et al.  Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. , 2002, Diabetes.

[100]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[101]  J. Connell,et al.  Direct Activation of AMP-activated Protein Kinase Stimulates Nitric-oxide Synthesis in Human Aortic Endothelial Cells* , 2003, Journal of Biological Chemistry.

[102]  M. Bucan,et al.  A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.

[103]  C. Bruce,et al.  AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle , 2005, The Journal of physiology.

[104]  L. Rossetti,et al.  Hypothalamic sensing of fatty acids , 2005, Nature Neuroscience.

[105]  N. Kimura,et al.  A possible linkage between AMP‐activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[106]  G. Barsh,et al.  AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. , 2007, The Journal of clinical investigation.

[107]  D. Carling,et al.  Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. , 2000, The Biochemical journal.

[108]  N. Fujii,et al.  Skeletal Muscle Adaptation to Exercise Training , 2007, Diabetes.

[109]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[110]  M. Birnbaum,et al.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.

[111]  G. Kobinger,et al.  Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. , 2003, American journal of physiology. Cell physiology.

[112]  R. Roy,et al.  Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling , 2006, Development.

[113]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[114]  D. Hardie,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[115]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[116]  D. Carling,et al.  Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. , 2007, The Biochemical journal.

[117]  N. Fujii,et al.  Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle -insight from analysis of a transgenic mouse model-. , 2007, Diabetes research and clinical practice.

[118]  G. Taffet,et al.  Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White Syndrome , 2005, Circulation.

[119]  D. Vertommen,et al.  Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis , 2002, Current Biology.

[120]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[121]  David Carling,et al.  Thr2446 Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status* , 2004, Journal of Biological Chemistry.

[122]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[123]  Kohjiro Ueki,et al.  Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. , 2007, Cell metabolism.

[124]  N. Fujii,et al.  AMP-activated Protein Kinase α2 Activity Is Not Essential for Contraction- and Hyperosmolarity-induced Glucose Transport in Skeletal Muscle* , 2005, Journal of Biological Chemistry.

[125]  B. Viollet,et al.  Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. , 2006, Diabetes.

[126]  K. Athenstaedt,et al.  The neurodegeneration mutant löchrig interferes with cholesterol homeostasis and Appl processing , 2002, The EMBO journal.

[127]  J. Wojtaszewski,et al.  AS160 phosphorylation is associated with activation of alpha2beta2gamma1- but not alpha2beta2gamma3-AMPK trimeric complex in skeletal muscle during exercise in humans. , 2007, American journal of physiology. Endocrinology and metabolism.

[128]  D. Fayuk,et al.  The Journal of Physiology , 1978, Medical History.

[129]  B. Viollet,et al.  Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice , 2007 .

[130]  S. Kihara,et al.  Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.

[131]  G. Weigel,et al.  Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres , 2006, Journal of Cell Science.

[132]  D. Hardie,et al.  Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. , 2002, American journal of physiology. Endocrinology and metabolism.

[133]  B. Viollet,et al.  Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. , 2005, Diabetes.

[134]  D. Hardie,et al.  5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.

[135]  S. Gygi,et al.  The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.

[136]  P. Flachs,et al.  Expression of the uncoupling protein 1 from the aP2 gene promoter stimulates mitochondrial biogenesis in unilocular adipocytes in vivo. , 2002, European journal of biochemistry.

[137]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[138]  B. Viollet,et al.  Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. , 2004, The Journal of biological chemistry.

[139]  J. Ninomiya-Tsuji,et al.  AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart , 2005, Circulation research.

[140]  H. Pilegaard,et al.  Higher skeletal muscle α2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise , 2006, The Journal of physiology.

[141]  B. Viollet,et al.  Anti-lipolytic Action of AMP-activated Protein Kinase in Rodent Adipocytes* , 2005, Journal of Biological Chemistry.

[142]  L. Kifle,et al.  Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. , 2006, Cell metabolism.

[143]  N. Fujii,et al.  Glucose Metabolism and Energy Homeostasis in Mouse Hearts Overexpressing Dominant Negative α2 Subunit of AMP-activated Protein Kinase* , 2003, Journal of Biological Chemistry.

[144]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[145]  N. Fujii,et al.  Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle , 2006, Diabetes.

[146]  J. Wojtaszewski,et al.  Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle , 2006, The Journal of physiology.

[147]  S. Hawley,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[148]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[149]  B. Viollet,et al.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. , 2003, The Journal of clinical investigation.

[150]  B. Viollet,et al.  Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. , 2007, American journal of physiology. Endocrinology and metabolism.

[151]  Uwe Riek,et al.  Dissecting the Role of 5′-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase* , 2006, Journal of Biological Chemistry.

[152]  B. Viollet,et al.  Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase , 2004, Nature Medicine.

[153]  Ferhaan Ahmad,et al.  Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.

[154]  M. W. Schwartz,et al.  Central nervous system control of food intake and body weight , 2006, Nature.

[155]  G. Shulman,et al.  AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[156]  B. Viollet,et al.  The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. , 2004, Diabetes.

[157]  George Thomas,et al.  Hypothalamic mTOR Signaling Regulates Food Intake , 2006, Science.

[158]  D. Hardie,et al.  AMPK: a key sensor of fuel and energy status in skeletal muscle. , 2006, Physiology.

[159]  C. Wyatt,et al.  Does AMP-activated Protein Kinase Couple Inhibition of Mitochondrial Oxidative Phosphorylation by Hypoxia to Calcium Signaling in O2-sensing Cells?* , 2005, Journal of Biological Chemistry.

[160]  B. Xue,et al.  AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues , 2006, The Journal of physiology.

[161]  Anita Y. M. Chan,et al.  Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte* , 2004, Journal of Biological Chemistry.

[162]  M. Birnbaum,et al.  AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.